How effective is docetaxel for prostate cancer?

How effective is docetaxel for prostate cancer?

After a median follow up of 50 months, the median OS achieved in the docetaxel plus ADT arm was 58.9 months compared with 54.2 months in the ADT arm [HR: 1.01; 95% CI (0.75, 1.36); p = 0.955].

What is the most common side effect of docetaxel?

The most common adverse reactions across all TAXOTERE indications are infections, neutropenia, anemia, febrile neutropenia, hypersensitivity, thrombocytopenia, neuropathy, dysgeusia, dyspnea, constipation, anorexia, nail disorders, fluid retention, asthenia, pain, nausea, diarrhea, vomiting, mucositis, alopecia, skin …

What are the long term side effects of docetaxel?

The most common long-term side effects of docetaxel are two types of nerve damage called sensory and motor peripheral neuropathy. Although it is less common, patients have also reported hair loss that lasts for years and appears to be permanent. In extremely rare cases, patients have developed leukemia.

How long can you stay on docetaxel?

What to Expect During Treatment. Health care providers administer Taxotere through an IV for one hour ever three weeks, according to the drug’s label. Depending on the type of cancer, this can continue for several cycles.

How many times can you have docetaxel?

Docetaxel is normally given once every three weeks, over about one hour. This is known as a cycle. The interval between each treatment gives your body time to recover.

Can HER2-positive be cured?

With recent advances in medicine, it is considered that HER2-positive breast cancer is curable. Targeted therapy is used to cure HER2-positive breast cancer. However, surgery, radiation therapy, chemotherapy and hormonal therapy may also be combined with targeted therapy depending on cancer aggressiveness.

How do you feel after docetaxel?

Docetaxel may cause severe lack or loss of strength, which can last a few days up to several weeks. Tell your doctor if you unusual tiredness or weakness. This medicine contains alcohol and may cause some people to become drowsy, dizzy, or less alert than they are normally.

How good is docetaxel?

Docetaxel has an average rating of 4.6 out of 10 from a total of 11 ratings on Drugs.com. 30% of reviewers reported a positive effect, while 50% reported a negative effect.

What is after docetaxel?

Both cabazitaxel and abiraterone are now approved for use in Canada for the treatment of mCRPC that has progressed during or after docetaxel-based chemotherapy. In addition, evidence is accumulating from trials of other agents, not yet approved in Canada, that offer a survival benefit in mCRPC.